CDI laboratory explores pathway to open up blood cancer treatments
(Hackensack Meridian Health) The CDI team's findings could ultimately improve cancer treatments for people of advanced age, like that of adult acute myeloid leukemia (AML). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2020 Category: Cancer & Oncology Source Type: news

Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?
The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia. (Source: CancerNetwork)
Source: CancerNetwork - February 13, 2020 Category: Cancer & Oncology Authors: Santiago Riviello-Goya, MD, Aldo A. Acosta-Medina, MD, Sergio I. Inclan-Alarcon, MD, Sofia Garcia-Miranda, MD, Christianne Bourlon, MD, MHSc Source Type: news

Bright idea in dentist's office leads to innovative smoking cessation project
Results from this study recently published online in Addiction found primary care physicians providing smokers with a free, two week starter kit of nicotine replacement therapy (NRT) increased quit attempts While sitting in the dentist's office, Hollings Cancer Center researcher Matthew Carpenter, Ph.D., of the Medical University of South Carolina, had a bright idea. As he received his goody bag with dental hygiene products, he wondered why not conduct a study and have primary care providers do the same thing for their patients who use tobacco. The bags would contain educational material, free lozenges and tobacco cessati...
Source: Dental Technology Blog - February 12, 2020 Category: Dentistry Source Type: news

Young Cancer Survivors at Higher Risk for Hospitalization
Risks most elevated for survivors of leukemia, CNS tumors, CRC, non - Hodgkin lymphoma, breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 12, 2020 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pediatrics, Journal, Source Type: news

FDA Lifts Clinical Hold for MultiTAA T-Cell Therapy Trial in Acute Myeloid Leukemia
The planned trial will investigate the safety and efficacy of the novel multi-tumor associated antigen T-cell therapy in patients with post-transplant acute myeloid leukemia. (Source: CancerNetwork)
Source: CancerNetwork - February 12, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Janssen Announces Submission to U.S. FDA for New DARZALEX ® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma
RARITAN, NJ, February 10, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexamethasone (DKd) for relapsed/refractory multiple myeloma. The sBLA is supported by results from the Phase 3 CANDOR study, which compared treatment with DKd to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who relapsed after one to three prior lines of therapy. “W...
Source: Johnson and Johnson - February 10, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cindy Crawford Shines a Light on the Need for Blood Donations with Give Blood to Give Time
“I was 8 years old when my brother was diagnosed with leukemia,” said Cindy Crawford. “I remember my parents coming home and telling us that. I didn’t really know what ... The post Cindy Crawford... {This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - February 10, 2020 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood American Cancer Society blood donation blood donor chemotherapy Cindy Crawford platelets whole blood Source Type: news

Early Findings Show Promise of CAR NK-Cell Therapy in Leukemia, Lymphoma
Patients with either relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with CAR NK cells had a response without the development of cytokine release syndrome, neurotoxicity, or graft-versus-host disease. (Source: CancerNetwork)
Source: CancerNetwork - February 8, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

When the Teenager or Young Adult Has Cancer
Adolescents and young adults are a special population of cancer patients. (Source: NYT Health)
Source: NYT Health - February 6, 2020 Category: Consumer Health News Authors: Mikkael A. Sekeres, M.D. Tags: Hospitals Chemotherapy Lymphoma Age, Chronological Cancer Leukemia Youth Doctors Source Type: news

CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma
(University of Texas M. D. Anderson Cancer Center) According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), with no major toxicities observed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

Phase I Trial Aims to Evaluate Cobomarsen in Certain Hematologic Malignancies
The phase I trial is evaluating cobomarsen in cancers where the disease process appears to be correlated with an increase in miR-155 levels, including adult T-cell leukemia/lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia. (Source: CancerNetwork)
Source: CancerNetwork - February 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

FDA clears investigational new drug application for Calibr's 'switchable' CAR-T therapy
(Scripps Research Institute) Calibr, the drug discovery and development division of Scripps Research, today announced that the US Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's 'switchable' CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 3, 2020 Category: International Medicine & Public Health Source Type: news

AbbVie Receives Positive CHMP Opinion for VENCLYXTO(R) as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
If approved by the European Commission (EC), VENCLYXTO® plus obinutuzumab would be the first chemotherapy-free, combination regimen given with a fixed duration for patients with previously untreated chronic lymphocytic leukemia (CLL) Represents thir... Biopharmaceuticals, Oncology, Regulatory AbbVie, VENCLYXTO, venetoclax, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

Roche announces CHMP recommendation for EU approval of Venclyxto plus Gazyvaro for people with untreated chronic lymphocytic leukaemia
Basel, 31 January 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Venclyxto® (venetoclax) in combination with Gazyvaro® (obinutuzumab) for the treatment of adults with previously untreated chronic lymphocytic leukaemia (CLL).“Despite advances in treating chronic lymphocytic leukaemia, many patients cannot tolerate the side effects of chemotherapy-containing regimens,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product ...
Source: Roche Investor Update - January 31, 2020 Category: Pharmaceuticals Source Type: news

15-year-old with cancer testifies weeks before dying against drug dealer who gave her meth for sex
A 15-year-old girl with leukemia testified before dying against the the man who supplied her meth and sexually assaulted her. (Source: CBC | Health)
Source: CBC | Health - January 30, 2020 Category: Consumer Health News Tags: News/Canada/Saskatoon Source Type: news

Georgia Sterilization Plant Hit with Hefty Fines for EtO Violation
An Atlanta, GA-based medical sterilization plant is learning an expensive lesson after missing a critical deadline related to ethylene oxide (EtO) pollution controls. Sterilization Services of Georgia received a permit on Nov. 7 to use EtO to sterilize medical devices, but the company was supposed to install filters to reduce the gas by Dec. 31. The filters were fully operational as of Jan. 18, according to a Jan. 20 letter, but the Georgia Environmental Protection Department (EPD) fined the company $3,000 for each day beyond the deadline that the filters were not connected. In the letter to the Geo...
Source: MDDI - January 30, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Sterilization Source Type: news

Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
The initiating mutations that contribute to cancer development are sometimes present in premalignant cells. Whether therapies targeting these mutations can eradicate premalignant cells is unclear. Acute myeloid leukemia (AML) is an attractive system for investigating the effect of preventative treatment because this disease is often preceded by a premalignant state (clonal hematopoiesis or myelodysplastic syndrome). In Npm1c/Dnmt3a mutant knock-in mice, a model of AML development, leukemia is preceded by a period of extended myeloid progenitor cell proliferation and self-renewal. We found that this self-renewal can be reve...
Source: ScienceNOW - January 30, 2020 Category: Science Authors: Uckelmann, H. J., Kim, S. M., Wong, E. M., Hatton, C., Giovinazzo, H., Gadrey, J. Y., Krivtsov, A. V., Rücker, F. G., Döhner, K., McGeehan, G. M., Levine, R. L., Bullinger, L., Vassiliou, G. S., Armstrong, S. A. Tags: Medicine, Diseases reports Source Type: news

Bone Marrow Transplants Less Risky Now
WEDNESDAY, Jan. 29, 2020 -- The risks faced by U.S. bone marrow transplant patients have dropped sharply, a new study shows. While this type of transplant can be lifesaving for patients with blood cancers (such as leukemia) and other diseases,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 29, 2020 Category: General Medicine Source Type: news

Single-cell sequencing of CLL therapy: Shared genetic program, patient-specific execution
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) Researchers at the CeMM Research Center for Molecular Medicine and partners in Budapest have studied the response to targeted leukemia therapy in unprecedented detail, using single-cell sequencing and epigenetic analysis. The paper published in Nature Communications uncovers a precise molecular program in patients with chronic lymphocytic leukemia (CLL) who start treatment with ibrutinib. While this program was shared by all patients, the speed of its execution differed widely. These results will help develop personalized strategies for manag...
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

Joseph Wynne, MD, Discusses Developments in the Field of Acute Lymphoblastic Leukemia
The ALL expert spoke about new research in the field and how it has changed the landscape for this disease. (Source: CancerNetwork)
Source: CancerNetwork - January 29, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

9/11 Workers May Be at Higher Cancer Risk
Ground zero workers had higher rates of cancer, especially prostate and thyroid cancers and leukemia. (Source: NYT Health)
Source: NYT Health - January 27, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: World Trade Center (Manhattan, NY) Cancer Prostate Cancer Thyroid Cancer Leukemia Mount Sinai Medical Center Source Type: news

Revealed an alteration related to the loss of effectiveness of a treatment in lung cancer
(Josep Carreras Leukaemia Research Institute) Researchers from IJC reveal that non-smoking patients with lung cancer that have an alteration in RB1 and are treated with EGFR inhibitors, acquire resistance to treatment through the mechanism of histopathological transformation, either to non-small cell lung cancer (SCLC) or SLCL combined with a transformation to squamous cell lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 23, 2020 Category: Cancer & Oncology Source Type: news

Leukaemia sufferer who wrote 'f*** cancer' on her bruised face dies aged 28
Kathryn Cartwright, of Sutton, Coldfield, became an inspirational figure since her leukaemia diagnosis 13 years ago. She died of an 'insurmountable' liver infection on January 18. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2020 Category: Consumer Health News Source Type: news

Male fertility after chemotherapy: New questions raised
(Institut national de la recherche scientifique - INRS) Professor Delb è s, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma. Their results, recently published in the journal Plos One, raise important questions about male fertility and the long-term quality of life of cancer survivors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2020 Category: Cancer & Oncology Source Type: news

Dasatinib Tops Imatinib for Ph + Acute Lymphoblastic Leukemia
Four - year cumulative risk of any relapse lower for dasatinib in the context of intensive chemotherapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 21, 2020 Category: Cancer & Oncology Tags: Oncology, Pathology, Pediatrics, Pharmacy, Journal, Source Type: news

Dasatinib Tops Imatinib for Ph & #43; Acute Lymphoblastic Leukemia
TUESDAY, Jan. 21, 2020 -- Dasatinib is associated with improved survival for pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), according to a study published online Jan. 16 in JAMA Oncology. Shuhong Shen,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2020 Category: Pharmaceuticals Source Type: news

Side Effect of CAR T Therapy Caused by Pyroptosis: Mouse Study
The immunotherapy induces a form of cell death in leukemia cells in mice that triggers cytokine release syndrome, a dangerous inflammatory reaction that occurs in some patients. (Source: The Scientist)
Source: The Scientist - January 20, 2020 Category: Science Tags: News & Opinion Source Type: news

Defining the Landscape of Mutations Present in Pediatric Acute Lymphoblastic Leukemia
This research has the potential to aid in the development of new strategies for early detection of relapse in pediatric patients with ALL, and the development of treatments to counter clinical occurrence. (Source: CancerNetwork)
Source: CancerNetwork - January 20, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Heartbreaking photograph of twins, 3, kissing as one is diagnosed with rare leukaemia
The snap comes as Fox Parkin, from Devon, is separated from his sister Winter for the first time for cancer treatment following his Acute Promyelocytic Leukaemia (APL) diagnosis. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2020 Category: Consumer Health News Source Type: news

Cheap drug may alleviate treatment-resistance in leukemia
(Karolinska Institutet) A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in mice and human blood cells performed at Karolinska Institutet and SciLifeLab and published in the medical journal EMBO Molecular Medicine. The researchers will now launch a clinical study to test the new combination treatment in patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2020 Category: International Medicine & Public Health Source Type: news

Idelalisib May Induce More Favorable Outcomes in Clinical Trial Participants, Versus Medicare Beneficiaries
Medicare beneficiaries saw unfavorable results when compared to clinical trial participants being treated with idelalisib for their follicular lymphoma or chronic lymphocytic leukemia. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

Boy, 5, with leukaemia is cancer-free after family fundraise £500,000 for life-saving treatment
Oscar Saxelby-Lee, from Worcester, was given a 'life or death' three-month race against time to find a stem-cell match after his aggressive form of leukaemia worsened. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2020 Category: Consumer Health News Source Type: news

Partnership with China prompts change in care for high-risk type of leukemia
(St. Jude Children's Research Hospital) Findings from a collaborative clinical trial have generated key insights into how targeted therapy should be used to treat leukemia driven by the Philadelphia chromosome. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 16, 2020 Category: Cancer & Oncology Source Type: news

Mutations in donors' stem cells may cause problems for cancer patients
(Washington University School of Medicine) A new study from Washington University School of Medicine in St. Louis suggests that extremely rare, harmful genetic mutations present in healthy donors' stem cells -- though not causing health problems in the donors -- may be passed on to cancer patients receiving stem cell transplants, potentially creating health problems for the recipients. Among the concerns are heart damage, graft-versus-host disease and possible new leukemias. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2020 Category: Cancer & Oncology Source Type: news

Research collaboration reveals promising drug candidate for treatment of blood cancers
(Children's Cancer Institute Australia) An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukemia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2020 Category: Cancer & Oncology Source Type: news

Green light for cancer treatment for BRCA mutations
Approved for platinum-sensitive ovarian cancer Related items fromOnMedica Experts disappointed at NICE decision on ovarian cancer drug Put case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company Debate goes on over valproate in pregnancy HPV programme linked to dramatic fall in cervical disease Quarter million people taking benzodiazepines for more than a year (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 15, 2020 Category: UK Health Source Type: news

Nearly 20 Years Later, Cancer Rates Higher in 9/11 First Responders
This particular group of responders appears to have an increased risk of developing thyroid cancer, leukemia and prostate cancer, as well as a slightly elevated overall risk of cancer, researchers report. (Source: WebMD Health)
Source: WebMD Health - January 14, 2020 Category: Consumer Health News Source Type: news

Responders who worked at the World Trade Center site following 9/11 have a greater risk of LEUKAEMIA
Police officers, firefighters and construction workers who inhaled toxic fumes at Ground Zero in Manhattan are 40 per cent more likely to be diagnosed with the blood cancer than the average person. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news

Cancer Incidence Up in World Trade Center Responder Cohort
Incidence up for all cancer sites combined and for prostate cancer, thyroid cancer, leukemia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 14, 2020 Category: Cancer & Oncology Tags: Endocrinology, Oncology, Urology, Journal, Source Type: news

Higher Incidence of Leukemia Found in 9/11 Responders Higher Incidence of Leukemia Found in 9/11 Responders
A significantly higher incidence of leukemia in responders to the September 11 World Trade Center attacks in New York City has been reported for the first time.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking ...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

Sept. 11 Responders May Be at Heightened Risk of Developing Leukemia
After the Twin Towers fell on Sept. 11, 2001, the thousands of people involved in rescue-and-cleanup efforts were exposed to carcinogens and other toxins as they breathed in contaminated air and dug through industrial rubble. Studies completed since then have shown elevated rates of conditions including multiple myeloma, prostate cancer and thyroid cancer among 9/11 responders and those who worked near the site. A new study published Jan. 14 in the journal JNCI Cancer Spectrum adds another to that list: leukemia. “After about 12 years of follow-up, there was an increase in the rate of all cancers combined, and separa...
Source: TIME: Health - January 14, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer Research Source Type: news

Elevated leukemia incidence is found in World Trade Center rescue and recovery workers
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Responders who worked at the World Trade Center site after the attacks on Sept. 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2020 Category: Cancer & Oncology Source Type: news

A solid vaccine for liquid tumors
(Wyss Institute for Biologically Inspired Engineering at Harvard) Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years. Chemotherapy has been the standard treatment for over 40 years, and while it often causes the cancer to go into remission, nearly half of patients experience disease relapse. Scientists at the Wyss Institute and Harvard SEAS have developed an injectable, biomaterial-based vaccine that, when combined with standard chemotherapy, caused complete and lasting recovery from and immunity against AML in mice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2020 Category: Cancer & Oncology Source Type: news

Vitamin B6, leukemia's deadly addiction
Scientists have discovered that Acute Myeloid Leukemia (AML) grows by taking advantage of the B6 vitamin to accelerate cell division. The research team from Cold Spring Harbor Laboratory (CSHL) and Memorial Sloan Kettering Cancer Center (MSK) suggest they could halt the growth of this cancer by limiting its ability to manipulate the enzyme that pushes B6 to make proteins essential for cell division. (Source: World Pharma News)
Source: World Pharma News - January 13, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Vitamin B6, leukemia's deadly addiction
(Cold Spring Harbor Laboratory) Researchers from CSHL and Memorial Sloan Kettering Cancer Center have discovered how Acute Myeloid Leukemia is addicted to vitamin B6. Now that researchers know this, they can pursue new treatment options for the deadly blood cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2020 Category: Cancer & Oncology Source Type: news

Naval Daver, MD, Provides Perspective on Updates in Acute Myeloid Leukemia
Naval Daver, MD, explains the progress made on 3 abstracts he ’s involved with regarding acute myeloid leukemia (AML) at the ASH Annual Meeting and Exposition. (Source: CancerNetwork)
Source: CancerNetwork - January 12, 2020 Category: Cancer & Oncology Authors: Naval Daver, MD Source Type: news

Patients With Acute Leukemias Have Increased Risk for Heart Failure, Study Shows
Researchers developed a risk score assessment to measure potential risk for chemotherapy-induced heart failure (Source: CancerNetwork)
Source: CancerNetwork - January 11, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news

Boy who beat cancer gets surprise greeting from entire school
When 6-year-old John Oliver finished chemo treatment for leukemia, he returned to school to a standing ovation from his classmates. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 10, 2020 Category: Consumer Health News Source Type: news

Indian boy blinded by leukaemia which made his eyes bleed and pop out can now see again
Sagar Dorji was just four years old when childhood leukemia caused his eyes to become swollen, bloodshot and come out of their sockets. Three years on little Sagar is free from cancer and he can see. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2020 Category: Consumer Health News Source Type: news